Market Overview
The Latin America hypodermic syringes and needles market reached a size of USD 207.12 Million in 2024 and is expected to grow to USD 365.07 Million by 2033, with a CAGR of 5.85% during the 2025-2033 forecast period. Key growth drivers include expanding vaccination programs, rising prevalence of chronic diseases, enhanced healthcare infrastructure, government safety initiatives, needle technology advancements, and increased awareness of needlestick injury prevention. The market shows promising growth and stability in the coming years.
Study Assumption Years
Base Year: 2024
Historical Years: 2019-2024
Forecast Years: 2025-2033
Latin America Hypodermic Syringes and Needles Market Key Takeaways
- The market size reached USD 207.12 Million in 2024.
- The CAGR is 5.85% for the forecast period 2025-2033.
- The market is projected to reach USD 365.07 Million by 2033.
- Extensive government-led immunization and vaccination initiatives, such as influenza vaccine purchases increasing in Argentina from 1.2 million to over 4 million doses by 2025, boost market growth.
- Increased government spending on healthcare infrastructure enhances access and supply of syringes and needles, exemplified by Brazil's USD 40 million allocation for aeromedical goods and services in 2024.
- The establishment of the Environmental Alliance of America promotes sustainable trade and eco-friendly syringe and needle development, supported by UN Environment Programme (UNEP).
- Market stability is reinforced through partnerships with global medical supply manufacturers ensuring continuous distribution of medical products.
Sample Request Link: https://www.imarcgroup.com/latin-america-hypodermic-syringes-needles-market/requestsample
Market Growth Factors
The market for hypodermic syringes and needles in Latin America is anticipated to be driven by increasing vaccination coverage and immunization programs. For example, by 2025, the number of flu vaccine doses purchased annually from Argentine manufacturers will increase from 1.2 million to more than 4 million, increasing availability while driving prices down. Joint interventions by Argentina's National Ministry of Health with other organizations like the Pan American Health Organization (PAHO) for access to safe, effective, quality, and affordable medicines and health technologies have benefited the market and the public health campaigns for epidemic control of communicable diseases like influenza and COVID-19 have led to the demand for quality syringes and needles.
Investment in healthcare infrastructure from the government can be a driver in the market. In 2024, Brazil's USD 40 million acquisition of aeromedical goods and services presented new procurement opportunities and partnership opportunities for suppliers. Increased public health budgets provide more syringes and needles. The move expands access to one of the most basic components of medical care, and is seen as critical for both routine medical care and vaccination. Other public health modernization efforts in the region seek to further improve care.
Sustainability is a market trend with the establishment of the Environmental Alliance of America in 2024 and, supported by the UN Environment Programme (UNEP), the first eco-labeling scheme in the region. A growing focus of scheme is sustainability. Increasing consumer knowledge on product sustainability allows for the production of biodegradable and recyclable syringes and needles. This subsequently reduces medical waste and environmental impact. Regulatory processes to favor more sustainable manufacturing technologies and capital investment into sustainability can further provide the foundation for a more sustainable healthcare system.
Market Segmentation
Product Insights:
Hypodermic Syringes: Includes conventional syringes and safety syringes broken down into retractable and non-retractable safety syringes, providing a comprehensive product range for different medical needs.
Hypodermic Needles: Comprised of conventional needles and safety needles designed to meet safety and operational effectiveness in healthcare.
End Use Insights:
Hospitals
Clinics
Ambulatory Surgical Centers
Veterinary
Home Care
Others
These segments reflect the diverse healthcare settings utilizing syringes and needles in Latin America.
Country Insights:
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
The report covers major regional markets, offering detailed country-level analyses.
Regional Insights
Brazil, Mexico, Argentina, Colombia, Chile, and Peru represent the major markets in Latin America for hypodermic syringes and needles. Brazil, with specific government initiatives like the USD 40 million allocation to aeromedical goods in 2024, stands out as a dominant market. The region is expected to exhibit a CAGR of 5.85% through 2033, driven by healthcare infrastructure growth and vaccination programs, ensuring strong opportunities across these countries.
Recent Developments & News
September 2024: The FDA approved B. Braun Medical's Introcan Safety 2 Deep Access IV Catheter, enhancing the catheter's dwell length to approximately 5.7 days from the usual 3.8 days. This new catheter reduces blood exposure and includes needlestick protection, benefiting patients with difficult vascular access.
August 28, 2024: The Brazilian Secretariat of International Trade (SECEX) initiated an antidumping investigation into hypodermic needle imports from China. Prompted by Becton Dickinson Indústrias Cirúrgicas Ltda., the investigation targets products under NCM code 9018.32.19, alleging a dumping margin of 16.93 USD/kg (261.7%). Stakeholders had until September 17, 2024, to participate.
Key Players
B. Braun Medical
Becton Dickinson Indústrias Cirúrgicas Ltda.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
